ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2011 Financial Results

* Reuters is not responsible for the content in this press release.

Wed Apr 20, 2011 7:30am EDT 

  IRVINE, CA, Apr 20 (MARKET WIRE) -- 
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced it will
release first quarter 2011 financial results after the market closes on
May 4, 2011. In conjunction, the Company will host a conference call to
review first quarter results and provide a business update at 4:30 p.m.
Eastern Time. 

    Date: Wednesday, May 4, 2011 

    Time: 4:30 p.m. Eastern Time

    Conference call access:
 Internet: www.istavision.com
 Domestic dial-in:
866-761-0749
 International dial-in: 617-614-2707
 Passcode: 51591817

    To access the 24-hour audio replay, U.S. and Canadian participants may
dial 888-286-8010; international participants may dial 617-801-6888. The
access code for the replay is 59551940. This conference call also will be
webcast live and archived on ISTA's website until June 1, 2011. 

    About ISTA Pharmaceuticals
 
 ISTA Pharmaceuticals, Inc., is the fourth
largest and fastest growing branded prescription eye care business in the
United States, with an expanding focus on allergy therapeutics. ISTA
currently markets four products, including treatments for ocular
inflammation and pain post-cataract surgery, glaucoma and ocular itching
associated with allergic conjunctivitis. The company's development
pipeline contains additional candidates in various stages of development
to treat dry eye, ocular inflammation and pain, and nasal allergies.
Headquartered in Irvine, California, ISTA generated revenues of $156.5
million in 2010. For additional information about ISTA, please visit the
corporate website at www.istavision.com.

    

Contacts

Investor Relations Contacts at ISTA Pharmaceuticals, Inc.:
Lauren Silvernail
949-788-5302 
lsilvernail@istavision.com 
Jeanie Herbert
949-789-3159
jherbert@istavision.com

Media and Additional Investor Relations Contacts at Burns McClellan: 
Justin Jackson
(Media)
212-213-0006
jjackson@burnsmc.com 
Juliane Snowden
(Investor Relations)
212-213-0006
jsnowden@burnsmc.com 

Copyright 2011, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.